IFNAR2 and COVID-19: This leads to a hypothesis that COVID-19 patients harboring IFNAR2 rs9975538 variant might be more likely to develop neurological disorders (Douaud et al., 2022; Lee et al., 2022), possibly though neuroinflammatory pathways.